7 Results for "

mPD-1

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "mPD-1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P70639
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Programmed cell death protein 1; PD-1; CD279; Pdcd1; mPD-1
Species:  
Source:  
Cat. No.: HY-183866
CAS No.: 1911555-88-8
Synonyms: Maleimide-KGDEVD-doxorubicin
Research Areas:  

Cancer

MPD-1 (Maleimide-KGDEVD-doxorubicin) is a peptide drug conjugate (PDC). MPD-1 releases Doxorubicin (HY-15142) via radiation-activated caspase-3 cleavage, triggering a cytotoxic amplification cascade at the tumor site. MPD-1 enhances CD8 + T cell tumor infiltration, and activates antigen-presenting cells. MPD-1 enables dual-trigger payload release, amplifies cytotoxicity via in situ feedback, and selectively delivers payload to tumor microenvironments via enhanced albumin metabolism and macropinocytosis. MPD-1 exhibits antitumor efficacy in mouse colorectal cancer models. MPD-1 can be used for the research of colorectal cancer [1] .
Cat. No.: HY-P704841
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Programmed cell death protein 1; PD-1; CD279; Pdcd1; mPD-1
Species:  
Source:  
Cat. No.: HY-P70640
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Programmed cell death protein 1; PD-1; CD279; Pdcd1; mPD-1
Species:  
Source:  
Cat. No.: HY-RS08905
Research Areas:  

Others

MYH7 Human Pre-designed siRNA Set A contains three designed siRNAs for MYH7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-178097
Target:  

MAP4K

Research Areas:  

Cancer

HPK1-IN-62 is a selective and orally active HPK-1 inhibitor with an IC50 of 1.22 nM. HPK1-IN-62 significantly improves GLK selectivity (> 665-fold) and LCK selectivity (> 1095-fold). HPK1-IN-62 enhances T-cell activation and demonstrated synergistic effects when combined with anti-mPD-1 therapy in the MC38 tumor model, inhibiting a tumor growth. HPK1-IN-62 can be used in the researchs of colon cancer and cancer immunotherapy [1].
Cat. No.: HY-P87094
Synonyms: Beta myosin heavy chain antibody; cardiac muscle beta isoform antibody; CMD1S antibody; CMH1 antibody; mPD1 antibody; MYH7 antibody; MYH7_HUMAN antibody; Myhc slow antibody; MyHC-beta antibody; MyHC-slow antibody; Beta myosin heavy chain antibody; cardiac muscle beta isoform antibody; CMD1S antibody; CMH1 antibody; mPD1 antibody; MYH7 antibody; MYH7_HUMAN antibody; Myhc slow antibody; MyHC-beta antibody; MyHC-slow antibody; MYHCB antibody; Myopathy, distal 1 antibody; Myosin heavy chain (AA 1-96) antibody; Myosin heavy chain 7 antibody; Myosin heavy chain antibody; Myosin heavy chain slow isoform antibody; Myosin heavy chain, cardiac muscle beta isoform antibody; Myosin, heavy chain 7, cardiac muscle, beta antibody; Myosin, heavy polypeptide 7, cardiac muscle, beta antibody; Myosin-7 antibody; Rhabdomyosarcoma antigen MU RMS 40.7A antibody; SPMD antibody; SPMM antibody;

Host:  

Rabbit

Application:  

WB, IHC-P, IF-Tissue, IHC-F

Reactivity:  

Human, Mouse, Rat